This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Waters Technologies Corporation. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Liuxi Chen: Innovator in Antibody-Drug Conjugate Analysis
Introduction
Liuxi Chen is a prominent inventor based in Saratoga, California. He has made significant contributions to the field of mass spectrometry, particularly in the analysis of antibody-drug conjugates (ADCs). His innovative work has the potential to enhance the understanding and development of therapeutic agents.
Latest Patents
Liuxi Chen holds a patent titled "Identification and quantification of conjugated peptides in antibody drug conjugates by mass spectrometry." This patent presents a streamlined, complete workflow for the qualitative and quantitative analysis of conjugated peptides from ADC compounds. His work in this area is crucial for advancing the efficacy and safety of drug formulations.
Career Highlights
Liuxi Chen is currently employed at Waters Technologies Corporation, a leading company in analytical instruments and software. His role at the company allows him to apply his expertise in mass spectrometry to real-world applications, contributing to the development of innovative solutions in the pharmaceutical industry.
Collaborations
Liuxi Chen has collaborated with notable colleagues, including Weibin Chen and Steven Cubbedge. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Liuxi Chen's contributions to the field of mass spectrometry and antibody-drug conjugates exemplify the impact of innovative thinking in science and technology. His work not only advances research but also holds promise for future therapeutic developments.